Polypoidal Choroidal Vasculopathy: Recent advances in therapy

G. de Crecchio; R. V P Chan; G. Manzi; M. R. Romano

doi:10.2174/138945011794182782

Polypoidal Choroidal Vasculopathy: Recent advances in therapy

G. de Crecchio, R. V P Chan, G. Manzi, M. R. Romano

Istituto Clinico Humanitas

Research output: Contribution to journal › Article › peer-review

Abstract

Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

Original language	English
Pages (from-to)	206-211
Number of pages	6
Journal	Current Drug Targets
Volume	12
Issue number	2
DOIs	https://doi.org/10.2174/138945011794182782
Publication status	Published - Jul 2012

Keywords

Age-related macular degeneration
AntiVEGF
Choroidal neovascularization
Combination therapy
Photodynamic therapy
Polypoidal choroidal vasculopathy
Triamcinolone

ASJC Scopus subject areas

Drug Discovery
Pharmacology
Clinical Biochemistry
Molecular Medicine

Access to Document

10.2174/138945011794182782

Cite this

@article{900351c4191a44f0993949f2ec321c00,

title = "Polypoidal Choroidal Vasculopathy: Recent advances in therapy",

abstract = "Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.",

keywords = "Age-related macular degeneration, AntiVEGF, Choroidal neovascularization, Combination therapy, Photodynamic therapy, Polypoidal choroidal vasculopathy, Triamcinolone",

author = "{de Crecchio}, G. and Chan, {R. V P} and G. Manzi and Romano, {M. R.}",

year = "2012",

month = jul,

doi = "10.2174/138945011794182782",

language = "English",

volume = "12",

pages = "206--211",

journal = "Current Drug Targets",

issn = "1389-4501",

publisher = "Bentham Science Publishers B.V.",

number = "2",

}

TY - JOUR

T1 - Polypoidal Choroidal Vasculopathy

T2 - Recent advances in therapy

AU - de Crecchio, G.

AU - Chan, R. V P

AU - Manzi, G.

AU - Romano, M. R.

PY - 2012/7

Y1 - 2012/7

N2 - Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

AB - Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

KW - Age-related macular degeneration

KW - AntiVEGF

KW - Choroidal neovascularization

KW - Combination therapy

KW - Photodynamic therapy

KW - Polypoidal choroidal vasculopathy

KW - Triamcinolone

UR - http://www.scopus.com/inward/record.url?scp=79955654604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955654604&partnerID=8YFLogxK

U2 - 10.2174/138945011794182782

DO - 10.2174/138945011794182782

M3 - Article

C2 - 20887241

AN - SCOPUS:79955654604

VL - 12

SP - 206

EP - 211

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 2

ER -

Polypoidal Choroidal Vasculopathy: Recent advances in therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this